Overview

Exploratory Clinical Study to Evaluate Sodium Oxybate (Xyrem) on Potential Endocrine Changes

Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
0
Participant gender:
All
Summary
To monitor for endocrine changes in response to treatment of cataplexy with Xyrem, to focus on the hypothalamic pituitary axis and to confirm the safety of Xyrem on potential endocrine changes.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
UCB Pharma SA
Treatments:
Sodium Oxybate
Criteria
Inclusion Criteria:

- Narcoleptic patients with cataplexy

Exclusion Criteria:

- Subjects not diagnosed with narcolepsy with cataplexy